Anastasia Khvorova (@wolkhv) 's Twitter Profile
Anastasia Khvorova

@wolkhv

ID: 279518901

calendar_today09-04-2011 12:41:16

158 Tweet

38 Followers

207 Following

Das Lab (@rdaslab) 's Twitter Profile Photo

Our #RNA multimer paper out now in @nature! #cryoEM of 2 distinct nanocages GOLLD and ROOL and membrane-associated OLE. Multimers at ultra-low concentrations, special covariance for cross-molecule kissing loops, and speculation on function nature.com/articles/s4158…. 1/2

Else Kröner-Fresenius-Stiftung (@ekfstiftung) 's Twitter Profile Photo

Else Kröner Fresenius Prize for Medical Research 2025: Anastasia Khvorova, professor of RNA therapeutics UMass Chan Medical School, is being honored with 2.5 million € for her pioneering work in the field of RNA-based therapies. Here is a preview of the award film. #EKFprize25 #RNA #Huntington

D2R | DNA to RNA (@d2rmcgill) 's Twitter Profile Photo

📢 RNA Canada|Canadian Consortium of RNA Researchers and Moderna’s The Discovery of the Year Award is open for nominations! This award recognizes groundbreaking RNA research by Canadian researchers. Nominate yourself or someone else today! 🗓️ Deadline: May 30, 2025 🏆 Prize: $7,000 🔗 rnacanada.ca/rna-canada-arn…

Nature Reviews Drug Discovery (@natrevdrugdisc) 's Twitter Profile Photo

For readers interested in GLP-1-based therapies for obesity, diabetes, metabolic liver disease, hypertension, neurodegenerative disorders and more, here's a comprehensive review nature.com/articles/s4157… rdcu.be/el0Ga

For readers interested in GLP-1-based therapies for obesity, diabetes, metabolic liver disease, hypertension, neurodegenerative disorders and more, here's a comprehensive review nature.com/articles/s4157…
rdcu.be/el0Ga
Eric Topol (@erictopol) 's Twitter Profile Photo

Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism" —the 1st human to undergo custom genome editing —outgrowth of decades of NIH funded research nejm.org/doi/full/10.10… nejm.org/doi/full/10.10… NEJM

Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism"
—the 1st human to undergo custom genome editing
—outgrowth of decades of NIH funded research
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10… <a href="/NEJM/">NEJM</a>
David R. Liu (@davidrliu) 's Twitter Profile Photo

Today in Science Magazine we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells, a collaboration with Sternberg Lab. 1/13 drive.google.com/file/d/1I-UbCR…

Today in <a href="/ScienceMagazine/">Science Magazine</a> we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells, a collaboration with <a href="/SternbergLab/">Sternberg Lab</a>.
1/13
drive.google.com/file/d/1I-UbCR…
John Maraganore 🇺🇦🇮🇱 (@jmaraganore) 's Twitter Profile Photo

Amazing story that highlights the transformative medicines that our research institutions and biotech companies can bring to patients and societies! We must preserve these advances for our future! wsj.com/tech/biotech/c…

Regeneron (@regeneron) 's Twitter Profile Photo

📣Today we announced that we intend to acquire 23andMe with plans to maintain their consumer genetics business and advance our shared goal of improving human health and wellness. bit.ly/43gI75D

Wenwen Fang (@wenwenfang2) 's Twitter Profile Photo

Excited to share our work on the structure of a natural RNA nanocage formed by the ROOL noncoding RNA, originally discovered by Zasha Weinberg and Ronald Breaker many years ago. Great collaboration with Xiaobin Ling, Jinbiao Ma, and Korostelev Lab! rdcu.be/erdqY

AtalantaTx (@atalantatx) 's Twitter Profile Photo

Atalanta Therapeutics announces leadership transitions, marking an important step in our continued progress to develop RNAi medicines for patients living with severe neurological diseases. Read more here: bit.ly/4e3SUFe #AtalantaTX

John Maraganore 🇺🇦🇮🇱 (@jmaraganore) 's Twitter Profile Photo

I stand with dozens of other biopharma leaders highlighting the potential catastrophic effects of proposed research cuts on bringing innovation to patients! statnews.com/2025/06/27/bio…

Clint Jarvis (@clinjar) 's Twitter Profile Photo

Stanford paid 35,000 people to quit social media. This was the largest study on emotional health in history. The results were so shocking, scientists called it "comparable to therapy." Here's what happens when you break free from the algorithm: 🧵

Stanford paid 35,000 people to quit social media.

This was the largest study on emotional health in history.

The results were so shocking, scientists called it "comparable to therapy."

Here's what happens when you break free from the algorithm:
 🧵
UMass Chan Medical School (@umasschan) 's Twitter Profile Photo

”Paul's dying wish was simple but profound: Find a cure for the incurables," said Swanee DiMare. UMass Chan Medical School's research building is now named for her husband, Paul J. DiMare. ”It stands as a tribute to the life he lived and a beacon of hope for the lives we still aim to save."

”Paul's dying wish was simple but profound: Find a cure for the incurables," said Swanee DiMare.

<a href="/UMassChan/">UMass Chan Medical School</a>'s research building is now named for her husband, Paul J. DiMare. 

”It stands as a tribute to the life he lived and a beacon of hope for the lives we still aim to save."
Oligonucleotide Therapeutics Society (@otsociety) 's Twitter Profile Photo

Students and postdocs - apply for a Travel Grant to attend the 2025 Annual Meeting! Travel Grants are between $1,000-$1,500 USD and funding may be available to assist with registration fees. Apply by July 15! Learn more at: oligotherapeutics.org/awards-grants/… #ots25 #ots

Students and postdocs - apply for a Travel Grant to attend the 2025 Annual Meeting!  

Travel Grants are between $1,000-$1,500 USD and funding may be available to assist with registration fees. 

Apply by July 15!

Learn more at: oligotherapeutics.org/awards-grants/…

#ots25 #ots